Search

Your search keyword '"Teisman A"' showing total 930 results

Search Constraints

Start Over You searched for: Author "Teisman A" Remove constraint Author: "Teisman A"
930 results on '"Teisman A"'

Search Results

52. JNJ-67569762, A 2-Aminotetrahydropyridine-Based Selective BACE1 Inhibitor Targeting the S3 Pocket: From Discovery to Clinical Candidate

53. Governance of sustainability at airports: Moving beyond the debate between growth and noise

59. Seizure-induced Torsades de pointes:In a canine drug-induced long-QT1 model

60. The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells

61. Tools for professional practice to facilitate business model development and market adoption of improved bioP2methane technology

62. Over de boeg van een akkoord

69. Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective

72. Employing complexity: complexification management for locked issues

75. Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose

76. Assessing Drug-Induced Long QT and Proarrhythmic Risk Using Human Stem-Cell-Derived Cardiomyocytes in a Ca2+ Imaging Assay: Evaluation of 28 CiPA Compounds at Three Test Sites

77. Abstracts of papers and posters Pharmacological Meeting

78. Abstracts of papers and posters

79. Use of microdialysis for monitoring sympathetic and parasympathetic innervation of heart in conscious rats

81. Employing Complexity: Complexification Management for Locked Issues

82. Employing complexity:complexification management for locked issues

83. Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes

91. Crystal Structure of BACE1 in complex with N-{3-[(4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide

94. Development of a Human iPSC Cardiomyocyte-Based Scoring System for Cardiac Hazard Identification in Early Drug Safety De-risking

96. Trifluoromethyl Dihydrothiazine‐Based β‐Secretase (BACE1) Inhibitors with Robust Central β‐Amyloid Reduction and Minimal Covalent Binding Burden

97. Crystal Structure of BACE1 in complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide

98. Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose

99. Assessing Drug-Induced Long QT and Proarrhythmic Risk Using Human Stem-Cell-Derived Cardiomyocytes in a Ca2+ Imaging Assay: Evaluation of 28 CiPA Compounds at Three Test Sites

100. PPPs: torn between two lovers: like the star-crossed experiment in Utrecht in the 1990s discussed in this article, PPPs may be doomed to fail. They mix two value patterns and organisational principles that cannot easily be combined. New management strategies are required to cross the 'borders'

Catalog

Books, media, physical & digital resources